THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHELEKHIN, Tatiana, MISCHKE, Steven, LI, Hongbin, CARAVELLA, Justin A, SCHILLER, Shawn E.R, WANG, Zhongguo, BAIR, Kenneth W, RICHARD, David, LANCIA, JR., David R, NG, Pui Yee, GUERIN, David Joseph, IOANNIDIS, Stephanos
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHELEKHIN, Tatiana
MISCHKE, Steven
LI, Hongbin
CARAVELLA, Justin A
SCHILLER, Shawn E.R
WANG, Zhongguo
BAIR, Kenneth W
RICHARD, David
LANCIA, JR., David R
NG, Pui Yee
GUERIN, David Joseph
IOANNIDIS, Stephanos
description The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3414251B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3414251B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3414251B13</originalsourceid><addsrcrecordid>eNqNyjEOwiAUBmAWB6Pe4V2gA7YeAPA1_IOAPJqoS9MYnIw2qfePiwdw-pZvrbh4cIjpms0NgcmZbOPFnHBkISM0WJwHFIRGEjv0cJRyLGyECcHDosQsW7V6TM-l7n5uFPVcnG_q_B7rMk_3-qqfkVPb6W5_0Fa3f5QvdMQsKA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS</title><source>esp@cenet</source><creator>SHELEKHIN, Tatiana ; MISCHKE, Steven ; LI, Hongbin ; CARAVELLA, Justin A ; SCHILLER, Shawn E.R ; WANG, Zhongguo ; BAIR, Kenneth W ; RICHARD, David ; LANCIA, JR., David R ; NG, Pui Yee ; GUERIN, David Joseph ; IOANNIDIS, Stephanos</creator><creatorcontrib>SHELEKHIN, Tatiana ; MISCHKE, Steven ; LI, Hongbin ; CARAVELLA, Justin A ; SCHILLER, Shawn E.R ; WANG, Zhongguo ; BAIR, Kenneth W ; RICHARD, David ; LANCIA, JR., David R ; NG, Pui Yee ; GUERIN, David Joseph ; IOANNIDIS, Stephanos</creatorcontrib><description>The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191016&amp;DB=EPODOC&amp;CC=EP&amp;NR=3414251B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191016&amp;DB=EPODOC&amp;CC=EP&amp;NR=3414251B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHELEKHIN, Tatiana</creatorcontrib><creatorcontrib>MISCHKE, Steven</creatorcontrib><creatorcontrib>LI, Hongbin</creatorcontrib><creatorcontrib>CARAVELLA, Justin A</creatorcontrib><creatorcontrib>SCHILLER, Shawn E.R</creatorcontrib><creatorcontrib>WANG, Zhongguo</creatorcontrib><creatorcontrib>BAIR, Kenneth W</creatorcontrib><creatorcontrib>RICHARD, David</creatorcontrib><creatorcontrib>LANCIA, JR., David R</creatorcontrib><creatorcontrib>NG, Pui Yee</creatorcontrib><creatorcontrib>GUERIN, David Joseph</creatorcontrib><creatorcontrib>IOANNIDIS, Stephanos</creatorcontrib><title>THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS</title><description>The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOwiAUBmAWB6Pe4V2gA7YeAPA1_IOAPJqoS9MYnIw2qfePiwdw-pZvrbh4cIjpms0NgcmZbOPFnHBkISM0WJwHFIRGEjv0cJRyLGyECcHDosQsW7V6TM-l7n5uFPVcnG_q_B7rMk_3-qqfkVPb6W5_0Fa3f5QvdMQsKA</recordid><startdate>20191016</startdate><enddate>20191016</enddate><creator>SHELEKHIN, Tatiana</creator><creator>MISCHKE, Steven</creator><creator>LI, Hongbin</creator><creator>CARAVELLA, Justin A</creator><creator>SCHILLER, Shawn E.R</creator><creator>WANG, Zhongguo</creator><creator>BAIR, Kenneth W</creator><creator>RICHARD, David</creator><creator>LANCIA, JR., David R</creator><creator>NG, Pui Yee</creator><creator>GUERIN, David Joseph</creator><creator>IOANNIDIS, Stephanos</creator><scope>EVB</scope></search><sort><creationdate>20191016</creationdate><title>THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS</title><author>SHELEKHIN, Tatiana ; MISCHKE, Steven ; LI, Hongbin ; CARAVELLA, Justin A ; SCHILLER, Shawn E.R ; WANG, Zhongguo ; BAIR, Kenneth W ; RICHARD, David ; LANCIA, JR., David R ; NG, Pui Yee ; GUERIN, David Joseph ; IOANNIDIS, Stephanos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3414251B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHELEKHIN, Tatiana</creatorcontrib><creatorcontrib>MISCHKE, Steven</creatorcontrib><creatorcontrib>LI, Hongbin</creatorcontrib><creatorcontrib>CARAVELLA, Justin A</creatorcontrib><creatorcontrib>SCHILLER, Shawn E.R</creatorcontrib><creatorcontrib>WANG, Zhongguo</creatorcontrib><creatorcontrib>BAIR, Kenneth W</creatorcontrib><creatorcontrib>RICHARD, David</creatorcontrib><creatorcontrib>LANCIA, JR., David R</creatorcontrib><creatorcontrib>NG, Pui Yee</creatorcontrib><creatorcontrib>GUERIN, David Joseph</creatorcontrib><creatorcontrib>IOANNIDIS, Stephanos</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHELEKHIN, Tatiana</au><au>MISCHKE, Steven</au><au>LI, Hongbin</au><au>CARAVELLA, Justin A</au><au>SCHILLER, Shawn E.R</au><au>WANG, Zhongguo</au><au>BAIR, Kenneth W</au><au>RICHARD, David</au><au>LANCIA, JR., David R</au><au>NG, Pui Yee</au><au>GUERIN, David Joseph</au><au>IOANNIDIS, Stephanos</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS</title><date>2019-10-16</date><risdate>2019</risdate><abstract>The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3414251B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T17%3A48%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHELEKHIN,%20Tatiana&rft.date=2019-10-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3414251B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true